Dimensional Fund Advisors LP increased its position in shares of HCP, Inc. (NYSE:HCP) by 2.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,668,908 shares of the real estate investment trust’s stock after acquiring an additional 130,892 shares during the quarter. Dimensional Fund Advisors LP owned approximately 1.42% of HCP worth $185,596,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Principal Financial Group Inc. raised its holdings in HCP by 475.0% in the 3rd quarter. Principal Financial Group Inc. now owns 4,284,833 shares of the real estate investment trust’s stock valued at $119,248,000 after buying an additional 3,539,670 shares during the period. Daiwa Securities Group Inc. raised its holdings in HCP by 15.4% in the 3rd quarter. Daiwa Securities Group Inc. now owns 12,243,041 shares of the real estate investment trust’s stock valued at $340,724,000 after buying an additional 1,632,319 shares during the period. Royal Bank of Canada raised its holdings in HCP by 353.7% in the 2nd quarter. Royal Bank of Canada now owns 1,826,053 shares of the real estate investment trust’s stock valued at $58,362,000 after buying an additional 1,423,582 shares during the period. Cbre Clarion Securities LLC raised its holdings in HCP by 18.1% in the 2nd quarter. Cbre Clarion Securities LLC now owns 9,223,958 shares of the real estate investment trust’s stock valued at $294,798,000 after buying an additional 1,413,760 shares during the period. Finally, BlackRock Inc. raised its holdings in HCP by 1.3% in the 2nd quarter. BlackRock Inc. now owns 46,580,421 shares of the real estate investment trust’s stock valued at $1,488,710,000 after buying an additional 599,578 shares during the period. 90.19% of the stock is currently owned by hedge funds and other institutional investors.

Shares of HCP, Inc. (NYSE:HCP) traded down $0.06 during trading hours on Tuesday, reaching $26.72. 3,070,800 shares of the company’s stock were exchanged, compared to its average volume of 3,670,647. The company has a debt-to-equity ratio of 1.17, a current ratio of 0.61 and a quick ratio of 0.61. The stock has a market capitalization of $12,562.72, a price-to-earnings ratio of 13.00, a PEG ratio of 2.85 and a beta of 0.38. HCP, Inc. has a one year low of $25.08 and a one year high of $33.67.

HCP (NYSE:HCP) last issued its quarterly earnings results on Thursday, November 2nd. The real estate investment trust reported $0.48 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.46 by $0.02. The company had revenue of $454.00 million for the quarter, compared to analyst estimates of $440.60 million. HCP had a net margin of 27.31% and a return on equity of 8.85%. The business’s revenue for the quarter was down 14.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.72 earnings per share. equities analysts forecast that HCP, Inc. will post 1.94 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 21st. Shareholders of record on Monday, November 6th were paid a dividend of $0.37 per share. The ex-dividend date was Friday, November 3rd. This represents a $1.48 dividend on an annualized basis and a yield of 5.54%. HCP’s dividend payout ratio (DPR) is presently 133.33%.

Several analysts recently issued reports on the stock. Stifel Nicolaus restated a “hold” rating and issued a $30.00 price objective on shares of HCP in a report on Wednesday, October 4th. BMO Capital Markets restated a “hold” rating and issued a $28.00 price objective on shares of HCP in a report on Wednesday, October 18th. KeyCorp restated a “hold” rating on shares of HCP in a report on Tuesday, October 17th. Morgan Stanley reduced their price objective on shares of HCP from $31.00 to $29.00 and set an “equal weight” rating on the stock in a report on Monday, September 25th. Finally, UBS lowered shares of HCP from a “neutral” rating to a “sell” rating and reduced their price objective for the company from $30.00 to $25.00 in a report on Monday, October 2nd. Three investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and three have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $30.91.

ILLEGAL ACTIVITY WARNING: “Dimensional Fund Advisors LP Purchases 130,892 Shares of HCP, Inc. (HCP)” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://www.watchlistnews.com/dimensional-fund-advisors-lp-purchases-130892-shares-of-hcp-inc-hcp/1759486.html.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.